Zobrazeno 1 - 6
of 6
pro vyhledávání: '"ORAYA KWANGSUKSTID"'
Autor:
Surakameth Mahasirimongkol, Athiwat Khunphon, Oraya Kwangsukstid, Sompong Sapsutthipas, Mingkwan Wichaidit, Archawin Rojanawiwat, Nuanjun Wichuckchinda, Wiroj Puangtubtim, Warangluk Pimpapai, Sakulrat Soonthorncharttrawat, Asawin Wanitchang, Anan Jongkaewwattana, Kanjana Srisutthisamphan, Daraka Phainupong, Naphatcha Thawong, Pundharika Piboonsiri, Waritta Sawaengdee, Thitiporn Somsaard, Kanokphon Ritthitham, Supaporn Chumpol, Nadthanan Pinyosukhee, Rattanawadee Wichajarn, Panadda Dhepakson, Sopon Iamsirithaworn, Supaporn Phumiamorn
Publikováno v:
Vaccines, Vol 10, Iss 4, p 536 (2022)
In response to the SARS-CoV-2 Delta variant, which partially escaped the vaccine-induced immunity provided by two doses of vaccination with CoronaVac (Sinovac), the National Vaccine Committee recommended the heterologous CoronaVac-ChAdOx1 (Oxford–A
Externí odkaz:
https://doaj.org/article/518ddbc5fd4a4ebe97eaf658e10ba8ca
Autor:
ORAYA KWANGSUKSTID1, WALAIORN PRATCHAYAPRUIT1, THAVATCHAI KAMOLTHAM1, MONTHAKA TEERACHAISAKUL2, AURACHORN INKANUWAT3 aurachorn@citu.tu.ac.th
Publikováno v:
Journal of Cosmetic Science. Jan/Feb2022, Vol. 73 Issue 1, p3-16. 14p.
Autor:
Jongjin Suwanthaweemeesuk, Chatip Phunmanee, Sasathorn Singthong, Oraya Kwangsukstid, Chavalit Supsrisunjai
Publikováno v:
International Journal of Dermatology and Venereology.
Autor:
Surakameth Mahasirimongkol, Athiwat Khunphon, Oraya Kwangsukstid, Sompong Sapsutthipas, Mingkwan Wichaidit, Archawin Rojanawiwat, Nuanjun Wichuckchinda, Wiroj Puangtubtim, Warangluk Pimpapai, Sakulrat Soonthorncharttrawat, Asawin Wanitchang, Anan Jongkaewwattana, Kanjana Srisutthisamphan, Daraka Phainupong, Naphatcha Thawong, Pundharika Piboonsiri, Waritta Sawaengdee, Thitiporn Somsaard, Kanokphon Ritthitham, Supaporn Chumpol, Nadthanan Pinyosukhee, Rattanawadee Wichajarn, Panadda Dhepakson, Sopon Iamsirithaworn, Supaporn Phumiamorn
Publikováno v:
Vaccines; Volume 10; Issue 4; Pages: 536
In response to the SARS-CoV-2 Delta variant, which partially escaped the vaccine-induced immunity provided by two doses of vaccination with CoronaVac (Sinovac), the National Vaccine Committee recommended the heterologous CoronaVac-ChAdOx1 (Oxford–A
Autor:
Kanjana Srisutthisamphan, Thitiporn Somporn, Kanokphon Ritthitham, Anan Jongkaewwattana, Archawin Rojanawiwat, Sopon Iamsiritahworn, Rattanawadee Wichajarn, Athiwat Khunphon, Daraka Phainupong, Supaporn Phumiamorn, Panadda Dhepaksorn, Pundharika Piboonsiri, Surakameth Mahasirimongkol, Warittha Sawaengdee, Nadthanan Pinyosukhee, Wiroj Puangtubtim, Supaporn Chumpol, Sompong Sapsutthipas, Penpitcha Thawong, Sakulrat Soonthorncharttrawat, Asawin Wanitchang, Warangluk Pimpapai, Oraya Kwangsukstid, Nuanjun Wichuckchinda, Minkwan Wichaidit
BackgroundResponding to SARS-CoV-2 Delta variants escaped the vaccine-induced immunity and waning immunity from the inactivated whole virus vaccine, Thailand recently proposed a heterologous inactivated whole virus vaccine (CoronaVac) viral vector va
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6ce5d6ad79e7e46dcad713d1b92564bc
https://doi.org/10.1101/2021.11.05.21264700
https://doi.org/10.1101/2021.11.05.21264700
Publikováno v:
Journal of the Medical Association of Thailand = Chotmaihet thangphaet. 96(8)
The Institute of Dermatology Thailand in cooperation with the hospitals across the country had conducted the psoriasis patient registry in Thailand between 2005 and 2008.To explore the epidemiology of psoriasis, distribution of disease and type of ps